The AHA PREVENT risk scoring model, which has replaced the prior Pooled Cohort Equations-based model in atherosclerotic cardiovascular disease (ASCVD) risk prediction, will be reviewed. Risk-based decisions regarding performance of additional atherosclerotic screening tools and treatment decisions will be examined. Lipid-lowering therapy goals are based on the risk estimate informed by demographic factors, laboratory testing, and imaging (e.g. coronary artery calcium score) results. This presentation reviews the literature surrounding lipoprotein(a) (Lp(a)) as a cardiovascular risk factor, including its genetic determinants, structure, and atherogenic mechanisms. The discussion will explore the atherogenic mechanisms of Lp(a), its genetic determinants, along with contemporary and future management strategies for elevated Lp(a). The webcast will also address the evolving role of aspirin in primary prevention, and the use of high-sensitivity C-reactive protein (hsCRP) in assessing atherosclerotic cardiovascular disease (ASCVD) risk.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Pricing
All courses included · $25
Courses are included in to obtain credit viewers must pay $25 to access the posttest if they are not a member of one of our subscribing hospitals or affiliated with OSU or OSUWMC; some are also sold individually.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- General Internal Medicine
- Geriatric Medicine
- Hematology
- Hospice & Palliative Medicine
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurocritical Care
- Nuclear Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Cardio-Vascular
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Primary care
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
$25
pay $25 to access the posttest if they are not a member of one of our subscribing hospitals or affiliated with OSU or OSUWMC
Listed by the provider · ccme.osu.edu
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Free to view · $25 for credit
-
ReleasedMay 1, 2026
-
Last day to claim creditMay 1, 2029 3 years left
-
American Academy of Family Physicians +2 Lipoprotein(a) Is Actionable Today! Advancing Guideline-Aligned Lp(a) Screening and Management in the Cardiology Setting
-
The Academy of Physician Associates in Cardiology (APAC) +1 Comprehensive Hyperlipidemia Care: Role of Lipoprotein(a) in ASCVD and Investigational Lipid-Lowering Agents
-
PRIME Education, Inc. (PRIME®) Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting
